E. Kellokoski

Ghrelin and obestatin modulate early atherogenic processes on cells: enhancement of monocyte adhesion and oxidized low-density lipoprotein binding.

Y. Kesäniemi, S. Mäkelä, A. Kunnari, 2009, Metabolism: clinical and experimental.

Estrogen replacement therapy increases plasma ghrelin levels.

J. Heikkinen, Y. Kesäniemi, O. Ukkola, 2005, The Journal of clinical endocrinology and metabolism.

The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes

H. Kauma, Y. Kesäniemi, O. Ukkola, 2005, Diabetologia.

Ghrelin vaccination decreases plasma MCP-1 level in LDLR−/−-mice

R. Serpi, P. Lehenkari, Y. Kesäniemi, 2009, Peptides.

Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes.

H. Kauma, Y. Kesäniemi, O. Ukkola, 2003, Diabetes.

Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males

M. Päivänsalo, H. Kauma, Y. Kesäniemi, 2006, Journal of internal medicine.

Ghrelin and atherosclerosis : human, experimental animal and cell culture studies

E. Kellokoski, Eija Kellokoski, 2009 .